Abstract
Several synthetic siRNAs were designed to target various regions of hepatitis C virus (HCV) replicon RNA. The antiviral efficacies of the siRNAs were compared using real time PCR and western blot assessment. siRNAs targeting either specific coding region of HCV NS3 or NS5B were the most efficacious in terms of gene silencing and inhibitory activity of the HCV replicon replication. There was no activation of genes involved in innate immune response by the HCV-specific siRNA, indicating that HCV replication inhibition was not due to non-specific antiviral response. Moreover, 5′-RACE PCR analysis showed that the silencing effect by the siRNAs was mainly caused by specific cleavage of targeted HCV genomic RNA. These findings suggest that RNAi targeting HCV coding regions could provide a useful approach to anti-HCV treatment.
Similar content being viewed by others
References
Bartenschlager R, Frese M, Pietschmann T (2004) Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63:71–180
Bernstein E, Causy AA, Hammond SM, Hannon GJ (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363–366
Brown KM, Chu CY, Rana TM (2005) Target accessibility dictates the potency of Human RISC. Nat Struct Mol Biol 12:469–470
De Francesco R (1999) Molecular virology of the hepatitis C virus. J Hepatol 312:47–53
Dykxhoorn DM, Lieberman J (2005) The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56:401–423
Elbashir SM, Lendeckel W, Tuschl T (2001a) RNA interference is mediated by 21 and 22-nucleotide RNAs. Genes Dev 15:188–200
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001b) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cell. Nature 411:494–498
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Hamilton AJ, Baulcombe DC (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286:950–952
Hugle T, Cerny A (2003) Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev Med Virol 13:361–371
Kafasla P, Morgner N, Poyry TAA, Curry S, Robinson CV, Jackson RJ (2009) Polypyrimidine tract binding protein stabilizes the encephalomyocarditis virus IRES structure via binding multiple sites in a unique orientation. Mol Cell 34:556–568
Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, Ansar M, Riazuddin S, Hassan S (2010) RNAi as a new therapeutic strategy against HCV. Biotechnol Adv 28:27–34
Krieger N, Lohmann V, Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75:4614–4624
Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52
Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113
Ryu KJ, Kim JH, Lee SW (2003) Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol Ther 7:386–395
Westerhout EM, Berkhout B (2007) A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acid Res 35:4322–4330
Acknowledgements
This study was supported by grants from the Korea Healthcare Technology R&D Project by the Korean Ministry for Health, Welfare & Family Affairs (A080173). B. Chang, C. H. Lee, and J. H. Lee are recipients of Brain Korea 21 fellowship.
Author information
Authors and Affiliations
Corresponding author
Additional information
Purpose of work RNA interference (RNAi), a specific gene silencing process mediated by small interfering RNA (siRNA) duplexes, has been evaluated as a therapeutic tool against hepatitis C virus (HCV).
Byeongyong Chang and Chang Ho Lee contributed equally.
Rights and permissions
About this article
Cite this article
Chang, B., Lee, C.H., Lee, J.H. et al. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs. Biotechnol Lett 32, 1231–1237 (2010). https://doi.org/10.1007/s10529-010-0298-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-010-0298-5